Ministry of Health adds Novavax to national vaccination scheme

Singaporeans can get the vaccine for free at selected clinics.

Starting 28 May, the Novavax/Nuvaxovid XBB.1.5 COVID-19 vaccine will be part of the National Vaccination Programme (NVP).

The Ministry of Health said eligible individuals can get the Novavax/Nuvaxovid XBB.1.5 vaccine for free at any participating general practitioner clinics offering COVID-19 vaccination.

The Expert Committee on Immunisation has recommended the Health Sciences Authority-approved vaccine for use in Singapore for ages 12 years and above.

Individuals unable to get mRNA COVID-19 vaccines are advised to consider the Novavax/Nuvaxovid XBB.1.5 vaccine, a protein subunit vaccine, except for those who caught myocarditis/pericarditis after an mRNA vaccine dose.

The previous formulation of the vaccine had been discontinued from the NVP on 1 January when the remaining local stock expired.

Follow the link for more news on

COVID-19

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia